Size optimization and in vitro biocompatibility studies of chitosan nanoparticles

被引:118
作者
Gomathi, Thandapani [1 ]
Prasad, P. Supriya [1 ]
Sudha, P. N. [1 ]
Anil, Sukumaran [2 ]
机构
[1] DKM Coll Women, Dept Chem, Vellore, Tamil Nadu, India
[2] Prince Sattam Bin Abdulaziz Univ, Div Periodont, Dept PDS, Coll Dent, Riyadh, Saudi Arabia
关键词
Size optimization; Hemocompatibility; Serum stability; Chitosan nanoparticles; MOLECULAR-STRUCTURE; GENE DELIVERY; PARTICLE-SIZE; CELL-LINE; DRUG; MICROSPHERES; FORMULATION; FABRICATION; RELEASE; SURFACE;
D O I
10.1016/j.ijbiomac.2017.08.057
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chitosan (CS), an amino polysaccharide has fascinating scientific applications due to its many flexible properties. The advantages of Chitosan tend to increase when it was modified. Thus, in the present research work, to improve the properties of chitosan, it was converted into chitosan nanoparticles (CS-NPs) through the ionic gelation method using sodium tripoyphosphate (TPP) and sodium hexametaphosphate (SHMP) as a crosslinker. The size optimization was done by varying the parameters such as crosslinker concentration, agitation method and rate, agitation time, temperature and drying method. The prepared samples were characterized using FTIR, TGA, XRD, SEM, TEM and DLS. Also the prepared CS-NPs with TPP and SHMP had been evaluated in vitro for determining its hemocompatibility, biodegradability, serum stability, cytotoxicity and cell viability. The results showed the significant participation of all the parameters in obtaining the nanoparticles in 20-30 nm and 5-10 nm for CS-NPs-TPP air dried and freeze dried samples and around 60-80 nm and 20-30 nm for CS-NPs-SHMP air dried and freeze dried samples. The in vitro biological studies revealed that the nanoparticles are non-toxic with a good degree of biodegradability, blood compatibility and stability. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:1794 / 1806
页数:13
相关论文
共 115 条
[41]   Fabrication by three-phase emulsification of pellicular adsorbents customised for liquid fluidised bed adsorption of bioproducts [J].
Jahanshahi, M ;
Pacek, AW ;
Nienow, AW ;
Lyddiatt, A .
JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 2003, 78 (11) :1111-1120
[42]   Docetaxel loaded chitosan nanoparticles: Formulation, characterization and cytotoxicity studies [J].
Jain, Ankit ;
Thakur, Kanika ;
Kush, Preeti ;
Jain, Upendra K. .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2014, 69 :546-553
[43]   Chitosan nanoparticles as delivery systems for doxorubicin [J].
Janes, KA ;
Fresneau, MP ;
Marazuela, A ;
Fabra, A ;
Alonso, MJ .
JOURNAL OF CONTROLLED RELEASE, 2001, 73 (2-3) :255-267
[44]   Preparation, characterization of hydrophilic and hydrophobic drug in combine loaded chitosan/cyclodextrin nanoparticles and in vitro release study [J].
Ji Jingou ;
Hao Shilei ;
Liu Weiqi ;
Wu Danjun ;
Wang Tengfei ;
Xu Yi .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2011, 83 (01) :103-107
[45]   A new lipid emulsion formulation with high antimicrobial efficacy using chitosan [J].
Jumaa, M ;
Furkert, FH ;
Müller, BW .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2002, 53 (01) :115-123
[46]   Chitosan: properties, preparations and application to microparticulate systems [J].
Kas, HS .
JOURNAL OF MICROENCAPSULATION, 1997, 14 (06) :689-711
[47]   Biodegradation, biodistribution and toxicity of chitosan [J].
Kean, T. ;
Thanou, M. .
ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (01) :3-11
[48]   Chitooligosaccharides -: preparation with the aid of pectinase isozyme from Aspergillus niger and their antibacterial activity [J].
Kittur, FS ;
Kumar, ABV ;
Varadaraj, MC ;
Tharanathan, RN .
CARBOHYDRATE RESEARCH, 2005, 340 (06) :1239-1245
[49]  
Knaul JZ, 1999, J APPL POLYM SCI, V72, P1721, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1721::AID-APP8>3.0.CO
[50]  
2-V